Thymocartin (TFA)
Thymocartin TFA is the TFA salt form of Thymocartin. Thymocartin TFA inhibits apoptosis of peripheral blood lymphocytes in HIV infected individuals. Thymocartin TFA is potential for immunodeficiency diseases research[1][2].
Product Specifications
Product Name Alternative
Thymopoietin II (32-35) (TFA) ; TP 4 (TFA)
UNSPSC
12352209
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/thymocartin-tfa.html
Purity
99.34
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(C)[C@@H](C(O)=O)NC([C@H](CC(O)=O)NC([C@H](CCCCN)NC([C@@H](N)CCCNC(N)=N)=O)=O)=O.O=C(C(F)(F)F)O.[x]
Molecular Formula
C21H40N8O7.xC2HF3O2
Molecular Weight
516.59 (free acid)
References & Citations
[1]la Szende B, et al., Reduction of apoptosis of in vitro cultured peripheral blood lymphocytes of HIV positive individuals by thymocartin[J]. Medical Science Monitor, 1997, 3 (4) : BR456-BR459.|[2] S Lang, et al. Transport and metabolic pathway of thymocartin (TP4) in excised bovine nasal mucosa. J Pharm Pharmacol. 1996 Nov;48 (11) :1190-6.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
